154 related articles for article (PubMed ID: 31322266)
1. Identification of driver genes and key pathways of prolactinoma predicts the therapeutic effect of genipin.
Zhong S; Wu B; Wang X; Sun D; Liu D; Jiang S; Ge J; Zhang Y; Liu X; Zhou X; Jin R; Chen Y
Mol Med Rep; 2019 Sep; 20(3):2712-2724. PubMed ID: 31322266
[TBL] [Abstract][Full Text] [Related]
2. PBK/TOPK Inhibitor Suppresses the Progression of Prolactinomas.
Zhu K; Cheng X; Wang S; Zhang H; Zhang Y; Wang X; Chen Y; Wu J
Front Endocrinol (Lausanne); 2021; 12():706909. PubMed ID: 35126305
[TBL] [Abstract][Full Text] [Related]
3. Identification of driver genes and key pathways of non-functional pituitary adenomas predicts the therapeutic effect of STO-609.
Wu B; Jiang S; Wang X; Zhong S; Bi Y; Yi D; Liu G; Hu F; Dou G; Chen Y; Wu Y; Dong J
PLoS One; 2020; 15(10):e0240230. PubMed ID: 33119597
[TBL] [Abstract][Full Text] [Related]
4. Identification of human prolactinoma related genes by DNA microarray.
Zhao L; Lin M; Wang S
J Cancer Res Ther; 2014; 10(3):544-8. PubMed ID: 25313736
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profile and differentially-expressed genes in prolactinomas following bromocriptine treatment.
Wang C; Su Z; Sanai N; Xue X; Lu L; Chen Y; Wu J; Zheng W; Zhuge Q; Wu ZB
Oncol Rep; 2012 May; 27(5):1312-20. PubMed ID: 22366961
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatics analyses of significant genes, related pathways and candidate prognostic biomarkers in glioblastoma.
Zhou L; Tang H; Wang F; Chen L; Ou S; Wu T; Xu J; Guo K
Mol Med Rep; 2018 Nov; 18(5):4185-4196. PubMed ID: 30132538
[TBL] [Abstract][Full Text] [Related]
7. Identification of Driver Genes and Key Pathways of Glioblastoma Shows JNJ-7706621 as a Novel Antiglioblastoma Drug.
Zhong S; Wu B; Dong X; Han Y; Jiang S; Zhang Y; Bai Y; Luo SX; Chen Y; Zhang H; Zhao G
World Neurosurg; 2018 Jan; 109():e329-e342. PubMed ID: 28989042
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis by genipin inhibits cell proliferation in AGS human gastric cancer cells via Egr1/p21 signaling pathway.
Ko H; Kim JM; Kim SJ; Shim SH; Ha CH; Chang HI
Bioorg Med Chem Lett; 2015 Oct; 25(19):4191-6. PubMed ID: 26283511
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
10. High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways.
Zhang X; Yang P; Luo X; Su C; Chen Y; Zhao L; Wei L; Zeng H; Varghese Z; Moorhead JF; Ruan XZ; Chen Y
Lipids Health Dis; 2019 Mar; 18(1):76. PubMed ID: 30922331
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.
Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R
Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134
[TBL] [Abstract][Full Text] [Related]
12. T5224, RSPO2 and AZD5363 are novel drugs against functional pituitary adenoma.
Zhong S; Wu B; Li J; Wang X; Jiang S; Hu F; Dou G; Zhang Y; Sheng C; Zhao G; Li Y; Chen Y
Aging (Albany NY); 2019 Oct; 11(20):9043-9059. PubMed ID: 31655798
[TBL] [Abstract][Full Text] [Related]
13. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of fibroblasts exposed to TGF‑β at the early proliferation phase of wound repair.
Mi B; Liu G; Zhou W; Lv H; Zha K; Liu Y; Wu Q; Liu J
Mol Med Rep; 2017 Dec; 16(6):8146-8154. PubMed ID: 28983581
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate target genes of pituitary adenomas based on the DNA microarray.
Zhou W; Ma CX; Xing YZ; Yan ZY
Mol Med Rep; 2016 Mar; 13(3):2182-6. PubMed ID: 26782791
[TBL] [Abstract][Full Text] [Related]
16. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-137 inhibits pituitary prolactinoma proliferation by targeting AKT2.
Xu Q; Yu ZX; Xie YL; Bai L; Liang SR; Ji QH; Zhou J
J Endocrinol Invest; 2023 Jun; 46(6):1145-1154. PubMed ID: 36427136
[TBL] [Abstract][Full Text] [Related]
18. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
Fang E; Zhang X; Wang Q; Wang D
Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
[TBL] [Abstract][Full Text] [Related]
19. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
Joshi H; Vastrad B; Vastrad C
J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
[TBL] [Abstract][Full Text] [Related]
20. Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database.
Lu X; Xue L; Sun W; Ye J; Zhu Z; Mei H
Mol Med Rep; 2018 Feb; 17(2):3042-3054. PubMed ID: 29257295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
